Advertisement
Screener

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Deferred Foreign Income Tax Expense (Benefit)

2.7 / 5 stars · 63/118 Roast Me

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Deferred Foreign Income Tax Expense (Benefit)

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Deferred Foreign Income Tax Expense (Benefit) of -$22.41 million for the 12-month period ending 2025-12-27, per its 10-K filed 2026-02-18.

Financial Statements › Expense Statement › Income Tax

us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2026-02-18

  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. deferred foreign income tax expense (benefit) for fiscal 2025 was -$22.41M.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. deferred foreign income tax expense (benefit) for fiscal 2024 was -$6.92M, a 988.58% decline from fiscal 2023.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. deferred foreign income tax expense (benefit) for fiscal 2023 was $779.00K.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. deferred foreign income tax expense (benefit) for fiscal 2022 was -$1.13M, a 108.16% decline from fiscal 2021.
Period endDeferred Foreign Income Tax Expense (Benefit) 12 month
2025-12-27-$22.41M
10-K · filed 2026-02-18
2024-12-28-$6.92M
10-K · filed 2026-02-18
2023-12-30$779.00K
10-K · filed 2026-02-18
2022-12-31-$1.13M
10-K · filed 2025-02-19
2021-12-25$13.89M
10-K · filed 2024-02-14
2020-12-26$5.58M
10-K · filed 2023-02-22
2019-12-28-$17.11M
10-K · filed 2022-02-16
2018-12-29-$4.10M
10-K · filed 2021-02-17
2017-12-30$14.95M
10-K · filed 2020-02-11
2016-12-31-$4.02M
10-K · filed 2019-02-13
2015-12-26$3.06M
10-K · filed 2018-02-13
2014-12-27-$4.67M
10-K · filed 2017-02-14
2013-12-28-$6.43M
10-K · filed 2016-02-12
2012-12-29-$12.68M
10-K · filed 2015-02-17
2011-12-31-$11.65M
10-K · filed 2014-02-25
2010-12-25-$9.70M
10-K · filed 2013-02-27
2009-12-26-$1.49M
10-K · filed 2012-02-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71